Introduction
Maintaining good nutritional status among HIV-infected children is clearly of paramount importance (1) . WHO guidelines for incorporating nutritional support into care programs for HIV-infected children are available for local adaptation (2) , and nutritional support services appear to be generally available at HIV care and treatment sites in sub-Saharan Africa (3) . However, the evidence-base for the effectiveness of specific nutritional interventions in HIVinfected children is weak (4) , and nutritional interventions impose additional costs on HIV care programs (5) . These costs could be reduced by developing locally-produced food-based supplements, which are also likely to be more palatable and culturally acceptable. Leaf concentrate is a foodbased nutritional supplement (6) which has been shown to be effective at preventing anemia in adolescent girls (7) and pregnant women (8) in India. Although anemia may actually be less prevalent among HIV-infected than among uninfected children (9) , it remains an important comorbidity and, together with other nutritional deficiencies and diarrheal disease, is a strong predictor of poor outcomes among children after initiation of antiretroviral therapy (ART) (10; 11; 12) .
Leaf concentrate was discovered in France in the 18 th century, and was developed as a foodstuff in England between 1940-1970 (13) . It has since been promoted by several nongovernmental organizations, including Leaf for Life in the USA (14) and the Association pour la Promotion des Extraits Foliaires en Nutrition (APEF) in France (15) , as a sustainable form of protein and micronutrient supplementation for low-income communities (6) . In this study, we investigate the potential benefits of dried lucerne (alfalfa) leaf concentrate as a nutritional supplement for HIV-infected ART-naïve children living in two cities in Burundi. The aim of the study was to determine the acceptability and palatability of leaf concentrate, and to measure its effectiveness (compared with skimmed milk powder) in relation to HIV-specific (viral load, CD4+ count) and general (haematological, anthropometric) parameters, and overall health.
Methods

Study population and recruitment
Our target population was antiretroviral-naïve HIV-positive children age 5-14 years. Children 
Ethical approval, trial registration and consent
Ethical approval for the study was granted on 16/06/2012 by the "Comité National d'Ethique pour la protection des êtres humains participants à la recherche biomédicale et comportementale" of Burundi. Written informed consent was obtained from the parent(s)/guardian(s) of eligible children, with original consent forms being held by ANSS.
Inclusion criteria
Children were eligible if they were ≥5 and ≤14 years old, had tested positive for HIV-1 (HIV 1/2 STAT-PAK® DIPSTICK Assay, Chembio Diagnostic Systems, Inc., 3661 Horseblock Road, Medford, NY 11763, USA), and had a CD4+ cell count ≥350 cells/mm 3(16) . Children with a CD4+ cell count <500 cells/mm 3 were required to receive prophylactic sulfamethoxazole/trimethoprim (2) . All children were dewormed before the study began using an appropriate dose of albendazole.
Exclusion criteria
Children were ineligible if they had a major concurrent illness (e.g. cancer, tuberculosis or diabetes), a BMI <12 kg/m 2 , were liable to move out of the study area or were unlikely to be able to receive the weekly supplements, or had participated in a clinical trial in the preceding 3 months.
Primary and secondary outcomes
Primary outcomes were percentage of CD4+ T lymphocytes, HIV viral load, and Hb measured after 6 months of follow-up. Secondary outcomes (also measured at 6 months)
included: anthropometric indices (height-for-age, weight-for-age, handgrip strength);
episodes of illness (diarrhea, respiratory); overall health (anemia, inflammation (CRP); fatigue, appetite); and palatability of the supplements (appearance, texture, taste).
Sample size
We aimed to recruit 42 children into each arm of the trial. This sample size was calculated to yield 90% power at a 5% level of significance to detect: a) equivalence between LCP and 
Randomization, allocation and adherence
Eligible children with consent to participate were allocated to LCP or SMP using a computergenerated random number sequence and consecutively-numbered sealed envelopes.
Envelopes were held and opened by a member of ANSS administrative staff not otherwise involved in the study, i.e. allocation was concealed from the ANSS medical staff who were running the trial. Delivery of supplements to all participants were made by ANSS health workers at an interval of 2 weeks and were recorded for each child. Observance of supplement consumption was monitored and discussed collectively (with all children and their parents) at each monthly monitoring visit in order to highlight difficulties and elaborate solutions. For the few parents who were not present at a supplement delivery time or reported difficulties in supplement consumption by their child, ANSS health workers visited them at home to see how supplements were consumed.
Leaf concentrate powder
The LCP group received 10g of lucerne (Medicago sativa) leaf concentrate powder (FranceLuzerne Agricultural Co-operative, 51130 Aulnay-aux-Planches, France). The leaf concentrate was contained in sachets, and could be taken orally by mixing with water or tea.
The composition of the LCP is shown in Table 1 .
Skimmed milk powder
The SMP group received 15g of skimmed milk powder (Société Industrielle Laitière du Léon, Le Raden, 29860 Plouvien, France). The skimmed milk powder was given in a sachet which could be taken orally by mixing with water or tea. The composition of the SMP is shown in Table 1 .
HIV-specific parameters and non-specific blood parameters
HIV-1 viral load, absolute count and percentage of CD4+ T lymphocytes (CD4%), and general blood parameters (Hb, WBC, lymphocytes, platelets, and CRP) were measured at baseline, 3 and 6 months in blood samples which were collected at ANSS clinics and 
Anthropometric parameters
Weight and height were measured using electronic scales and standing measurement boards during clinic visits at baseline, 3 and 6 months. Height-for-age and weight-for-age z-scores were estimated against British 1990 (UK90) growth charts (17; 18) . The UK90 BMI reference provides centile curves for children from birth to 23 years, based on a sample of 32,222 measurements from 12 distinct surveys in British children collected between 1978 and 1994.
Handgrip strength was measured, using a Jamar® hydraulic hand dynamometer (Patterson Medical, Nottinghamshire, UK), by two successive trials on the dominant side with the elbow at 90°, the maximal score of the two trials being recorded.
Diarrhea, respiratory infection, appetite, fatigue and overall health levels
Diarrhea, respiratory infection and other illnesses were recorded by ANSS clinicians monthly and during clinic visits at baseline, 3 and 6 months. Disease occurrences and corresponding treatments were recorded for each child in order to detect the medical events during each three months period (0-3months, 3-6months). Appetite, fatigue and overall health were assessed by questioning parents/carers at baseline, 3 and 6 months, with the following possible responses: fatigue (none, moderate, severe); appetite (weak, satisfactory, good, very good); overall health (very poor, poor, satisfactory, good, excellent).
Palatability
Three aspects of palatability (appearance, texture and taste) were recorded by ANSS health workers during clinic visits at 3 and 6 months, with the following possible responses:
appearance (unappealing, acceptable, appealing, very appealing); texture (unappealing, acceptable, appealing, very appealing); taste (very bad, bad, acceptable, good, very good).
Statistical analyses
Data were entered into a computer using Microsoft Excel, and were analyzed using Stata Between-group differences in continuous outcome measures were estimated using linear regression models. Between-group differences in binary outcome measures were tested using Fisher's exact tests. We fitted linear regression models using generalized estimating equations for each continuous outcome measure, including an interaction term between study arm and time-point (0, 3 or 6 months) to estimate within-and between-group changes at each time-point. We used an exchangeable within-child correlation structure (which assumes that the observations within a subject are equally correlated), and we verified by inspection that other correlation structures (ar1 and ar2) did not produce different results.
Results
Characteristics of trial participants
The median age of the participants was 10 years (range 5 to 14 years) and 39.8% (33/83) were male ( Table 2) . 42 children were randomized to receive SMP, and 41 to LCP (Figure   1 ).
Loss to follow-up and adherence
One child in the SMP arm and two children in the LCP arm did not receive their allocated intervention and dropped out at the beginning of the trial (Figure 1) . One child in the LCP arm dropped out just after the 3-month follow-up. Three children in each arm had an HIV viral load <350cells/mm 3 measured at the 3-month follow-up and proceeded to receive antiretroviral therapy. At 6 months, primary and secondary outcome measures were available for 90.5% (38/42) and 85.4% (35/41) of participants in the SMP and LCP groups, respectively. The final analysis was performed on the 38 SMP and 35 LCP children who had data on one or more outcome measures at the 6 months follow-up.
Blood parameters
The 95% confidence intervals of the between-group differences in percentage of CD4+ T lymphocytes and HIV-1 viral load at 6 months suggested non-equivalence between SMP and LCP ( Table 3) . For CD4+ percentage, equivalence had been defined as a difference not greater than 5%, but the 95% CI for the between-group difference in this parameter at 6 months was -1.17% to 6.07%, i.e. the upper bound exceeded 5% (in favour of LCP).
Similarly, equivalence for HIV viral load had been defined as a difference not greater than 0.5 logs, but the 95% CI of the observed difference was -0.19 to 0.67, i.e. the upper bound exceeded 0.5 (in favour of SMP). However, the 95% CI for the baseline values of these two HIV-related measures were also consistent with non-equivalence (suggesting the role of chance). Adjusted for baseline, the between-group differences at 6 months for CD4+
percentage and HIV viral load were 0.59% (95% CI -1.42% to 2.61%) and 0. 
Anthropometric parameters
Height-for-age and weight-for-age Z-scores increased to the same degree in both groups of children over the 6 months, and there was no additional effect of LCP over SMP ( Table 4) .
There were no between-group differences in median handgrip strength scores at 3 or 6
months, but children in the LCP group increased their (geometric mean) handgrip strength score 2.4-fold over the 6 months, compared with no change in the SMP group (Table 4) .
Diarrhea, respiratory infection and other illnesses
There were few reported cases of diarrhea during the study in either group: in the LCP group, 4 cases at baseline, then 1 case during 0-3 months and 1 case during 3-6 months follow-up; in the SMP group, 3 cases at baseline, no cases during 0-3 or 3-6 months follow-up. Pneumonia was reported to be present only once in each group, in both cases, during 3-6 months follow- 
Discussion
During 6 months of follow-up in this population of HIV-positive ART-naïve children, LCP was equivalent to SMP, after adjustment for baseline values, in relation to HIV-specific blood parameters (which showed little or no change in either group), and did not demonstrate superiority over SMP in relation to Hb levels (which increased in both groups). Higher levels of appetite and overall health were reported for children in the LCP group, and they also had higher handgrip strength scores. There were no differences in any of the other outcome measures. In terms of palatability, LCP was less acceptable than SMP to the children in this population, but with few negative ratings of appearance, texture and taste.
Our study was powered to detect equivalence in relation to HIV-specific blood parameters iron content of LCP). Differences between the two groups at baseline (which could only have arisen by chance) exceeded the thresholds for equivalence, suggesting that a wider a priori equivalence interval was required. However, the fully-adjusted analysis using longitudinal linear regression models gave estimates which were consistent with equivalence in the primary outcome measures. No differences were detected in any of the other outcome measures, although assessment of 'appetite', 'overall health' and handgrip strength at 6 months appeared to favour LCP. Several participants were lost to follow-up from each arm of the study, which would have reduced the power of the study, and the study was not sized to detect pre-specified differences in the secondary outcome measures. Allocation to the supplementation arms was concealed, but children and their parents/carers and field workers
were not blinded to allocation.
In the fifteen or so years since paediatric HIV came to be regarded as a chronic disease (19) , very little research has been conducted into the nutritional aspects of HIV infection in children age ≥5 years. Even for children under 5 years old, the evidence-based for nutritional interventions remains weak. The most recent Cochrane review reported some evidence for beneficial effects of vitamin A, zinc and micronutrient supplements, based on seven trials in sub-Saharan African countries (4) . This dearth of evidence may have arisen because children and adolescents fall into a gap between research into HIV infection during pregnancy and infancy (because of the focus on vertical transmission) and during adulthood (wherein lies the main 'burden' of HIV infection, in terms of numbers of people infected), or it may have arisen because nutritional interventions have proven to be less effective than expected, given observational evidence for the importance of nutrition among people infected with HIV (20) .
In policy terms, it has been acknowledged that children, together with adolescents (girls in particular), are being "left behind" in global efforts to end the AIDS epidemic (21) . This may be attributable in part to success in reducing the incidence of new infections in children, which have fallen by 58% from a peak of 580,000 in 2002. However, in 2013 there were an estimated 240,000 new infections, and 3.2 million children under 15 were living with HIV, 91% of whom were in sub-Saharan Africa. Given that these children are more likely to live in food-insecure households (1) , that HIV infection is associated with faltering growth to at least 10 years of age (22) , and that micronutrient sufficiency might be an important adjunct to antiretroviral therapy (23) , effective and sustainable approaches to maintaining adequate nutrition for HIV-infected children in resource-poor settings should be a priority area for research.
In the absence of comparable studies of nutritional interventions among ART-naïve children age 5-14 years, and because our study did not have an unsupplemented control group, we can only conclude that children receiving leaf concentrate and dairy supplements had equivalent outcomes in terms of CD4 percentage and HIV viral load. We cannot conclude that either supplement had any effect on these two outcomes, i.e. equivalence may indicate lack of effect. The higher iron content of the leaf concentrate supplement did not have any additional effect on Hb levels, for which there was evidence of improvement in both groups. This result may be attributable to the relatively normal baseline hemoglobin levels and/or to the consumption of LCP within tea (an inhibitor of iron absorption). Similar improvements in inflammation and fatigue were detected in both arms. Although both supplements contained zinc, the amounts are unlikely to have had an effect on diarrhea, for which some evidence of a protective effect of zinc supplementation has been reported (4) . The leaf concentrate supplement contained much higher levels of β-carotene than did the skimmed milk powder, but our study was not designed to detect differential effects of leaf concentrate on outcomes such as diarrhea and cough, for which evidence of beneficial effects of vitamin A supplementation is reasonably consistent (4) .
That growth indices improved in both groups is reassuring, given the accuracy with which these outcomes can be measured and the 6-month duration of our study. Classical anthropometric indices improved to the same degree in both groups, whereas handgrip strength score increased at a higher level in the LCP group. These data, combined with impact on appetite and overall health, suggest that LCP may increase the nutritional status more efficiently than SMP, because a relationship has been highlighted between muscle mass and function in children (24; 25) . These differences need to be confirmed by a larger study, ideally comparing LCP to no supplement (or to a supplement with known effects), and perhaps providing larger amounts of supplement or in conjunction with other nutrients.
HIV-infected adults have increased energy requirements (26) , and additional calories are recommended by WHO for HIV-positive children (27) , particularly in children experiencing weight loss. In our study, even greater gains in height and weight might have been achieved had the supplements been used to fortify a calorific snack, something which should be considered for future trials in this population. Incorporating the supplements into isocaloric biscuits could also address the issue of blinding (if the non-LCP biscuits were dyed green), and might improve adherence and acceptability (28) . The calcium content of both supplements might be expected to ameliorate low bone mass, an effect of HIV infection that has been reported for children and adolescents (29) , although longer follow-up would probably be required to detect any such effects. Trials which aim to test novel dietary interventions would benefit from information obtained from qualitative research into local tastes and preferences (30) . Such research would, ideally, be conducted before the trial, but could also be conducted during the trial.
Leaf concentrate might be considered as a candidate ingredient for the food multimix (FMM) concept (31) . The aim of FMM is to combine locally-available and commonly-consumed food ingredients into a culturally-acceptable end product which makes the best use of each ingredient's nutritional 'strengths'. Although our study compared LCP against SMP, parallel production of the two supplements is rendered eminently feasible by the unique capacity of the leaf fractionation concept to provide direct access to the edible fraction of the leaves and to provide feed for livestock. For example, lucerne grown on 1 hectare can generate the production of 2,000 kg of SMP if consumed directly by cattle; the same lucerne, fractionated into LCP for human consumption, fibre cake and whey for cattle can still produce 1,800 kg of SMP, with the added production of 1,200 kg of LCP (6) . In this context, our demonstration that the nutritional qualities of SMP and LCP are comparable is an important finding.
The acceptability of leaf concentrate, and any economic advantage that it may have over industrially-sourced skimmed milk powder, remains to be determined. Much as local and sustainable production of leaf concentrate is espoused as a key selling point (6) , this remains somewhat theoretical, and the development of the leaf fractionation concept is an ongoing process. In the case of Burundi, as in many tropical and sub-tropical countries, vegetables constitute a far greater component of the traditional diet than dairy products (32) , and vegetable crops (including those with leaves which are suitable for leaf concentrate production, e.g. beans) are one of the main agricultural products (33) .
These uncertainties should not deter further pursuit of alternative food-based solutions, including leaf fractionation, to nutritional problems among impoverished and vulnerable communities, particularly where local resilience might be needed in the face of endemic food insecurity and episodic civil instability (34; 35) . In the meantime, our small study in a particularly vulnerable group has demonstrated that a leaf-derived food supplement could meet this need as effectively as a conventional milk-based supplement. * The between-group difference corresponding to the "0-6 month change" shows the estimated additional effect of leaf concentrate powder compared with milk powder, i.e. the interaction term between the intervention and 6-month time-point. † Adjusted for age, sex and all blood parameters. ‡ Values shown for baseline, 3-and 6-month levels of handgrip strength are geometric mean (95% CI). Between-group difference and 0-6 month changes are ratios of geometric means from linear regression of log-transformed handgrip strength values, e.g. coefficient = 1.10 indicates that strength is 10% higher in LCP group compared with SMP group, coefficient = 0.90 indicates that strength is 10% lower in LCP group compared with SMP group, coefficient = 1.00 indicates no difference/change.
